AI-based Clinical Trial Solutions for Patient Matching Market by Therapeutic Application (Cardiovascular Diseases, Infectious Diseases, Metabolic Diseases, Oncology, Neurological Diseases, Others), by End-user (Academia, Pharmaceutical Companies, Others), and by Region - Global Forecast to 2023-2033

The AI-based clinical trial solutions market size is estimated to be USD 235.21 million in 2022 and is expected to witness a CAGR of 27.21% during the forecast period 2023-2033. The adoption of AI-powered solutions in managing and performing clinical trials, growing government activities to encourage the use of artificial intelligence (AI) technologies in the healthcare industry, rising healthcare expenditure by major players, and growing public awareness of AI-based technology are projected to drive the market growth in near future. However, issues associated with data privacy is predicted to limit market growth.

Growing government activities to encourage the use of artificial intelligence (AI) technologies in the healthcare industry is expected to drive the market growth. Government entities in industrialised countries such as U.S. and Europe are funding the development of AI-based clinical trial study solutions even while establishing a strict regulatory framework. Additionally, developing country governments are training stakeholders about AI-based clinical trial solutions so that they may concentrate on finding novel treatments and expediting patient enrollment, which will increase patient engagement and monitoring.

Rising healthcare expenditure by major players is projected to propel the market growth. Healthcare IT expenditures account for a sizable portion of healthcare costs in developed nations. Countries are implementing AI-based solutions to lower expenses and boost productivity. For instance, in September 2022, the National Institutes of Health (NIH) launched the Bridge2AI project, which will include participants from many organizations and focus on developing various tools, resources, and data for developing an AI strategy.

Segmentation

By Therapeutic Application

The market is categorized into cardiovascular diseases, infectious diseases, metabolic diseases, oncology, neurological diseases, and others. In 2022, the oncology segment accounted for the highest revenue share due to the rising prevalence of cancer worldwide. Leading pharmaceutical corporations are collaborating with AI development company to deploy AI-based oncology technologies designed for the development of pharmaceuticals. For instance, a collaboration between Deep Lens and Hematology-Oncology Associates of Central New York in January 2022 will be centred on the extension of the medical trial program’s clinical trial programs. By pre-screening all patients, the VIPER by Deep Lens will be used to categorize the patients who are qualified for clinical trials. Growth in the segment is further driven by the introduction of new technologies. For instance, Survivor Net introduced an AI-based clinical trial locator in June 2022 that connects individuals with cancer who are in need with advanced cancer research.

By End User

The market is categorized into academia, pharmaceutical companies, and others. In the global market, pharmaceutical companies the segment accounted for the largest revenue share in 2022 owing to increasing emphasis on developing biomarkers and diagnostics. For instance, text mining system Linguamatics from IQVIA offers NLP-based solutions for pharmaceutical companies. The pharmaceutical industry is expanding as a result of the rising prevalence of chronic diseases and the increase in demand for customized therapy. The market is also benefitting from a partnership between major pharmaceutical companies and AI providers for the implementation of AI technology designed for the complete medicine development process. However, it is anticipated that the others segment would have the fastest CAGR during the forecast period. The growth can be credited to the growing use of AI-based solutions by government entities and research organizations (CROs), as these solutions lower the cost of clinical trials by improving the quality of data, rising patient compliance & retention, and more precisely determining the efficacy of the treatment.

Regional Markets

 

In 2022, North America region accounted for the highest revenue in the AI-based clinical trial solutions market and is expected to maintain its dominance during the forecast period. This is attributed to existence of major companies in the area and increase in the number of start-ups using AI. Additionally, the region has a significant number of registered clinical studies, which benefits the industry. According to data from the World Health Organization (WHO), the United States conducted the most clinical trials, approximately 157,618 trials, between 1999 and 2021. The region’s growth is further spurred by the increasing government schemes for the use of AI-based technologies and the rising preference in these technologies. However, the Asia Pacific region is anticipated to exhibit the market’s quickest CAGR during the forecast period as a result of rising adoption of clinical technologies based on AI, increasing number of clinical studies, and government efforts.

Competitor Insights

Some of the key players operating in the AI-based clinical trial solutions market are AmerisourceBergen Corporation, Aris Global, Antidote Technologies, Inc., Deep Lens, Unlearn.AI, Inc., Deep6.ai, Koneksa, Microsoft Corporation, Mendel.ai, and GNS Healthcare.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

  • For instance, Deep Lens AI and Oregon Oncology Specialists entered into a strategic partnership in April 2021 to deploy a Deep Lens AI-powered clinical trial solution for identifying individuals who are eligible for clinical trial trials.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including therapeutic application and end user from 2022 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 235.21 Million
CAGR
  • 27.21%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Therapeutic Application
  • End user
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: AI-based Clinical Trial Solutions for Patient Matching Market Report 2022 – 2033

Therapeutic Application (Revenue, USD Million), 2022 – 2033

  • Cardiovascular Diseases
  • Infectious Diseases
  • Metabolic Diseases
  • Oncology
  • Neurological Diseases
  • Others

End user (Revenue, USD Million), 2022 – 2033

  • Academia
  • Pharmaceutical Companies
  • Others

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: AI-based Clinical Trial Solutions for Patient Matching Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
  1. Introduction: AI-based Clinical Trial Solutions for Patient Matching
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: AI-based Clinical Trial Solutions for Patient Matching Market  
  3. Market Analysis by Therapeutic Application
    1. Cardiovascular Diseases
      1. Cardiovascular Diseases Market Forecast, 2022-2033(USD Million)
    2. Infectious Diseases
      1. Infectious Diseases Market Forecast, 2022-2033(USD Million)
    3. Metabolic Diseases
      1. Metabolic Diseases Market Forecast, 2022-2033(USD Million)
    4. Oncology
      1. Oncology Market Forecast, 2022-2033(USD Million)
    5. Neurological Diseases
      1. Neurological Diseases Market Forecast, 2022-2033(USD Million)
    6. Others
      1. Others Market Forecast, 2022-2033(USD Million)
  1. Market Analysis byEnd User
    1. Academia
      1. Academia Market Forecast, 2022-2033(USD Million)
    2. Pharmaceutical Companies
      1. Pharmaceutical Companies Market Forecast, 2022-2033(USD Million)
    3. Others
      1. Others Market Forecast, 2022-2033(USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
  2. North America AI-based Clinical Trial Solutions for Patient Matching Market  
    1. North America AI-based Clinical Trial Solutions for Patient Matching Market
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. S. AI-based Clinical Trial Solutions for Patient Matching Market
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. Canada AI-based Clinical Trial Solutions for Patient Matching Market
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. Europe AI-based Clinical Trial Solutions for Patient Matching Market  
    1. Europe AI-based Clinical Trial Solutions for Patient Matching Market
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. Germany AI-based Clinical Trial Solutions for Patient Matching Market
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. UK AI-based Clinical Trial Solutions for Patient Matching Market
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
          2. France AI-based Clinical Trial Solutions for Patient Matching Market
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
              2. Market Size and Forecast by End User, 2022-2033(USD Million)
            2. Spain AI-based Clinical Trial Solutions for Patient Matching Market
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
                2. Market Size and Forecast by End User, 2022-2033(USD Million)
              2. Italy AI-based Clinical Trial Solutions for Patient Matching Market
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
                  2. Market Size and Forecast by End User, 2022-2033(USD Million)
                2. Rest of Europe AI-based Clinical Trial Solutions for Patient Matching Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
                    2. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market  
    1. Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. Japan AI-based Clinical Trial Solutions for Patient Matching Market
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. China AI-based Clinical Trial Solutions for Patient Matching Market
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
          2. India AI-based Clinical Trial Solutions for Patient Matching Market
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
              2. Market Size and Forecast by End User, 2022-2033(USD Million)
            2. South Korea AI-based Clinical Trial Solutions for Patient Matching Market
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
                2. Market Size and Forecast by End User, 2022-2033(USD Million)
                3. Market Size and Forecast by Device, 2022-2033(USD Million)
              2. Australia AI-based Clinical Trial Solutions for Patient Matching Market
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
                  2. Market Size and Forecast by End User, 2022-2033(USD Million)
                2. Rest of Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
                    2. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. Latin America AI-based Clinical Trial Solutions for Patient Matching Market  
    1. Latin America AI-based Clinical Trial Solutions for Patient Matching Market
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. Brazil AI-based Clinical Trial Solutions for Patient Matching Market
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. Mexico AI-based Clinical Trial Solutions for Patient Matching Market
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
          2. Argentina AI-based Clinical Trial Solutions for Patient Matching Market
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
              2. Market Size and Forecast by End User, 2022-2033(USD Million)
            2. Rest of Latin America AI-based Clinical Trial Solutions for Patient Matching Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
                2. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. MEA AI-based Clinical Trial Solutions for Patient Matching Market  
    1. MEA AI-based Clinical Trial Solutions for Patient Matching Market
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. GCC AI-based Clinical Trial Solutions for Patient Matching Market
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. South Africa AI-based Clinical Trial Solutions for Patient Matching Market
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
          2. Rest of MEA AI-based Clinical Trial Solutions for Patient Matching Market
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Therapeutic Application, 2022-2033(USD Million)
              2. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. AmerisourceBergen Corporation
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Aris Global
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Antidote Technologies, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Deep Lens
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. AI, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. ai
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. Koneksa
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Microsoft Corporation
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. ai
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. GNS Healthcare
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players
  3. Conclusion & Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.